1 1 K E N D R I C K R O A D R E A D I N G
B E R K S H I R E
R G 1 5 D U
TEL: 0118 920 7040
1 0 H A R L E Y S T R E E T
M A R Y L E B O N E
L O N D O N
W 1 G 9 P F
Year Qualified: 2002
GMC number: 6056963
Memberships: MBChB DPhil FRCS(Urol)
Minimally invasive and robotic surgery
Management of urological cancers
Treatment for Benign Prostatic Enlargement including UroLift & Rezum
Investigation of blood in the urine or semen
Management of general urological conditions effecting the male and female urinary tract
Valentina Dakpogan 0118 920 7040
Mr Chris Blick is a Consultant Urological Surgeon who has a subspeciality interest in urological cancers, particularly laparoscopic and robotic renal and bladder surgery. Mr Blick is also high trained and skilled at general and diagnostic urology.
Mr Chris Blick carried out his specialist urological training in the Oxford deanery within the hospitals of Oxfordshire, Berkshire, and Buckinghamshire. He completed his specialist training with a British Association of Urological Surgeons Fellowship to the Keck Institute of Medicine, University of Southern California, USA. This was under the tutorship of Professor Inderbir Gill, a world renowned pioneer and international leader of robotic renal and bladder surgery. His team has the world's most extensive experience of robotic renal and bladder surgery having carried out over 13,000 procedures.
Prior to specialist training, Mr Chris Blick was awarded competitive fellowship grants by The Royal College of Surgeons, The Urology Foundation and UCare. This supported 3 years of full time laboratory based scientific research in kidney and bladder cancer. Following this, Mr Chris Blick has published extensively in the clinical and scientific literature on kidney and bladder cancer and after completing his thesis was awarded a DPhil (PhD) by Christ Church, University of Oxford.
During specialist training, Mr Chris Blick was elected by his peers as Chairman of the Specialist Urology Registrars Group (SURG). Mr Blick represented the views and educational needs of all the UK and Irish specialist urological trainees / residents over the 3 years of his chairmanship.
Mr Chris Blick also has a particular interest in clinical trials. He was successful in becoming the first urological trainee member of the National Institute of Heath Research (NIHR) clinical studies group (CSG). He currently sits on the national renal and bladder cancer CSG and the UK cancer screening and early prevention group of the NIHR.
Mr Blick is also a member of the editorial board of the Journal of Clinical Urology and is the UK representative at the Board of the European Association of Urology (young Urologist office).He has published over 30 papers and has presented his work at a number of international and national meetings.
Mr Blick now is able to offer Rezum, for suitable patients with benign prostate symtoms. Please see below for further information: